Immune Checkpoint Inhibitor-Induced Pneumonitis in Non-Small Cell Lung Cancer: A Narrative Review of Incidence and Clinical Risk Factors.

Aseyev O, Zrielykh L, Shi M, Filipovic K, Seymour C, Siddiqui R, Biman B.

Open source

DOI
10.3390/curroncol33050240
Published
2026-04-22
Container
Curr Oncol
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/curroncol33050240,
  title = {Immune Checkpoint Inhibitor-Induced Pneumonitis in Non-Small Cell Lung Cancer: A Narrative Review of Incidence and Clinical Risk Factors.},
  author = {Aseyev O and  Zrielykh L and  Shi M and  Filipovic K and  Seymour C and  Siddiqui R and  Biman B.},
  year = {2026},
  journal = {Curr Oncol},
  doi = {10.3390/curroncol33050240},
  url = {https://doi.org/10.3390/curroncol33050240}
}

RIS

TY  - JOUR
TI  - Immune Checkpoint Inhibitor-Induced Pneumonitis in Non-Small Cell Lung Cancer: A Narrative Review of Incidence and Clinical Risk Factors.
AU  - Aseyev O
AU  -  Zrielykh L
AU  -  Shi M
AU  -  Filipovic K
AU  -  Seymour C
AU  -  Siddiqui R
AU  -  Biman B.
PY  - 2026
JO  - Curr Oncol
DO  - 10.3390/curroncol33050240
UR  - https://doi.org/10.3390/curroncol33050240
ER  - 

APA

O, A., L, Z., M, S., K, F., C, S., R, S., & B., B. (2026). Immune Checkpoint Inhibitor-Induced Pneumonitis in Non-Small Cell Lung Cancer: A Narrative Review of Incidence and Clinical Risk Factors.. Curr Oncol. https://doi.org/10.3390/curroncol33050240

Source records